I'm an obesity reversal specialist from India, you can check my profile on featured.com, will be glad to contribute.
I can provide commentary from the perspective of a clinician who works extensively with metabolic disease and high risk patients. In my practice, I routinely see how saturated fat interacts with insulin resistance, inflammation, and overall cardiovascular risk, and the study's finding makes sense clinically: the patients who benefit most from reducing saturated fat are the ones whose metabolic systems are already under significant strain. I manage many individuals with obesity, diabetes, and what's sometimes referred to as "type 3 diabetes," and when we lower inflammation, stabilize glucose, and reduce saturated fat in those high-risk groups, we consistently see improvements in cardiovascular markers and overall mortality risk.
Founder & Medical Director at New York Cosmetic Skin & Laser Surgery Center
Answered 4 months ago
As a dermatologist who sees metabolic skin changes all the time, I follow cardiovascular nutrition research closely, though I am not a cardiologist or obesity specialist. For a MedCentral feature on saturated fat and mortality, I would want your main commentary to come from someone with that board certification. In my own clinic, I still watch how improvements in diet, weight and lipids often run alongside calmer psoriasis or hidradenitis. In terms of substance, large cohort data show that replacing saturated fat with polyunsaturated fat can cut coronary events in high risk groups by around twenty to thirty percent, particularly when saturated fat drops below about ten percent of daily calories. That nuance, where benefit concentrates in people with existing metabolic or cardiovascular disease, is why a cardiologist or obesity specialist voice matters most here.